These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 1282522)

  • 1. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement.
    Celada P; Pérez J; Alvarez E; Artigas F
    J Clin Psychopharmacol; 1992 Oct; 12(5):309-15. PubMed ID: 1282522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brofaromine (CGP 11 305 A) in treatment of depression: biological estimation of plasma concentrations.
    Fritze J; Becker T; Ziegler V; Laux G; Riederer P
    Pharmacopsychiatry; 1990 May; 23(3):131-4. PubMed ID: 2374771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
    Chouinard G; Saxena BM; Nair NP; Kutcher SP; Bakish D; Bradwejn J; Kennedy SH; Sharma V; Remick RA; Kukha-Mohamad SA
    Clin Neuropharmacol; 1993; 16 Suppl 2():S51-4. PubMed ID: 8313397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAO inhibition and clinical response in depressed patients treated with phenelzine.
    Bresnahan DB; Pandey GN; Janicak PG; Sharma R; Boshes RA; Chang SS; Gierl BL; Davis JM
    J Clin Psychiatry; 1990 Feb; 51(2):47-50. PubMed ID: 2298705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors.
    Georgotas A; Friedman E; McCarthy M; Mann J; Krakowski M; Siegel R; Ferris S
    Biol Psychiatry; 1983 Feb; 18(2):195-205. PubMed ID: 6830930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible monoamine oxidase-A inhibitors in resistant major depression.
    Nolen WA; Hoencamp E; Bouvy PF; Haffmans PM
    Clin Neuropharmacol; 1993; 16 Suppl 2():S69-76. PubMed ID: 8313400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of serotonergic and noradrenergic neurotransmissions by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat central nervous system.
    Blier P; De Montigny C; Azzaro AJ
    J Pharmacol Exp Ther; 1986 Jun; 237(3):987-94. PubMed ID: 2423685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of neurochemical effects of the monoamine oxidase inhibitors phenelzine, moclobemide and brofaromine in the rat after short- and long-term administration.
    Urichuk LJ; Allison K; Holt A; Greenshaw AJ; Baker GB
    J Affect Disord; 2000 May; 58(2):135-44. PubMed ID: 10781703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration.
    Birkenhäger TK; van den Broek WW; Fekkes D; Mulder PG; Moleman P; Bruijn JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1084-8. PubMed ID: 17467132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic and side-effect profile of a selective and reversible MAO-A inhibitor, brofaromine. Results of dose-finding trials in depressed patients.
    Schiwy W; Heath WR; Delini-Stula A
    J Neural Transm Suppl; 1989; 28():33-44. PubMed ID: 2677240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term sertraline treatment and peripheral biochemical markers in female depressed patients.
    Pivac N; Mück-Seler D; Sagud M; Jakovljević M; Mustapić M; Mihaljević-Peles A
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):759-65. PubMed ID: 12921906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment dexamethasone suppression test as a predictor of response to phenelzine.
    Janicak PG; Pandey GN; Sharma R; Boshes R; Bresnahan D; Davis JM
    J Clin Psychiatry; 1987 Dec; 48(12):480-2. PubMed ID: 3693333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression.
    Merikangas KR; Merikangas JR
    Biol Psychiatry; 1995 Nov; 38(9):603-10. PubMed ID: 8573662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenelzine treatment of melancholia.
    McGrath PJ; Stewart JW; Harrison W; Wager S; Quitkin FM
    J Clin Psychiatry; 1986 Aug; 47(8):420-2. PubMed ID: 3525522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin uptake inhibition by the monoamine oxidase inhibitor brofaromine.
    Waldmeier PC; Graf T; Germer M; Feldtrauer JJ; Howald H
    Biol Psychiatry; 1993 Mar; 33(5):373-9. PubMed ID: 8471696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase inhibition by phenelzine and brofaromine in healthy volunteers.
    Bieck PR; Firkusny L; Schick C; Antonin KH; Nilsson E; Schulz R; Schwenk M; Wollmann H
    Clin Pharmacol Ther; 1989 Mar; 45(3):260-9. PubMed ID: 2920501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin and 5-hydroxyindoleacetic acid in plasma. Potential use as peripheral measures of MAO-A activity.
    Celada P; Sarrias MJ; Artigas F
    J Neural Transm Suppl; 1990; 32():149-54. PubMed ID: 1708403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential response patterns to MAO inhibitors and tricyclics.
    Nies A
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels.
    Griebel G; Curet O; Perrault G; Sanger DJ
    Neuropharmacology; 1998 Jul; 37(7):927-35. PubMed ID: 9776388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.
    McGrath PJ; Stewart JW; Nunes EN; Quitkin FM
    J Clin Psychiatry; 1994 Aug; 55(8):336-9. PubMed ID: 8071301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.